89581-82-8 Usage
Uses
Used in Pharmaceutical Industry:
2-Acetyl-3-chlorothiophene is used as a key intermediate in the synthesis of various pharmaceuticals due to its strong electrophilic character, which facilitates its involvement in multiple chemical reactions necessary for drug development.
Used in Agricultural Chemicals:
2-ACETYL-3-CHLOROTHIOPHENE is utilized as a building block in the production of pesticides and herbicides, contributing to the development of agricultural chemicals that are essential for crop protection and yield enhancement.
Used in Fragrance and Flavor Industries:
2-Acetyl-3-chlorothiophene is employed as a key ingredient in the synthesis of diverse compounds used in the fragrance and flavor industries, capitalizing on its ability to contribute to the creation of unique scents and tastes in various consumer products.
Check Digit Verification of cas no
The CAS Registry Mumber 89581-82-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,9,5,8 and 1 respectively; the second part has 2 digits, 8 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 89581-82:
(7*8)+(6*9)+(5*5)+(4*8)+(3*1)+(2*8)+(1*2)=188
188 % 10 = 8
So 89581-82-8 is a valid CAS Registry Number.
InChI:InChI=1/C6H5ClOS/c1-4(8)6-5(7)2-3-9-6/h2-3H,1H3
89581-82-8Relevant academic research and scientific papers
"one-Pot" Synthesis of γ-Pyrones from Aromatic Ketones/Heteroarenes and Carboxylic Acids
Sun, Xiangyu,Gong, Ming,Huang, Mengmeng,Li, Yabo,Kim, Jung Keun,Kovalev, Vladimir,Shokova, Elvira,Wu, Yangjie
, p. 15051 - 15061 (2020/12/02)
Despite the various attractive properties of γ-pyrones, there are still some deficiencies in their synthetic approaches such as lower atom economy, multistep processes, and prefunctionalization of the reagents. In this work, an efficient and simple (CF3CO
Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
-
Page/Page column 300, (2015/11/16)
The present invention is directed to inhibitors of S-nitrosoglutathione reductase (GSNOR), pharmaceutical compositions comprising such GSNOR inhibitors, and methods of making and using the same.
